A detailed history of Kilter Howling LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Kilter Howling LLC holds 622 shares of LLY stock, worth $494,906. This represents 0.35% of its overall portfolio holdings.

Number of Shares
622
Previous 622 -0.0%
Holding current value
$494,906
Previous $564 Million 2.15%
% of portfolio
0.35%
Previous 0.38%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

May 03, 2023

BUY
$296.48 - $337.87 $296 - $337
1 Added 0.16%
622 $201 Million
Q2 2022

May 03, 2023

BUY
$278.73 - $327.27 $173,091 - $203,234
621 New
621 $201 Million
Q1 2022

May 03, 2023

SELL
$234.69 - $291.66 $238,445 - $296,326
-1,016 Closed
0 $0
Q4 2021

May 03, 2023

BUY
$224.85 - $279.04 $228,447 - $283,504
1,016 New
1,016 $281 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $756B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Kilter Howling LLC Portfolio

Follow Kilter Howling LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kilter Howling LLC, based on Form 13F filings with the SEC.

News

Stay updated on Kilter Howling LLC with notifications on news.